Cited 8 times in

Dyslipidemia Fact Sheet in South Korea, 2022

Authors
 Eun-Sun Jin  ;  Jee-Seon Shim  ;  Sung Eun Kim  ;  Jae Hyun Bae  ;  Shinae Kang  ;  Jong Chul Won  ;  Min-Jeong Shin  ;  Heung Yong Jin  ;  Jenny Moon  ;  Hokyou Lee  ;  Hyeon Chang Kim  ;  In-Kyung Jeong  ;  Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis 
Citation
 Journal of Lipid and Atherosclerosis, Vol.12(3) : 237-251, 2023-09 
Journal Title
Journal of Lipid and Atherosclerosis
ISSN
 2287-2892 
Issue Date
2023-09
Keywords
Cholesterol ; Disease management ; Dyslipidemias ; Health behavior ; Prevalence ; Republic of Korea
Abstract
Objective: This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name Dyslipidemia Fact Sheet 2022.

Methods: We analyzed the lipid profiles, age-standardized and crude prevalence, management status of hypercholesterolemia and dyslipidemia, and health behaviors among Korean adults aged ≥20 years, using the Korea National Health and Nutrition Examination Survey data between 2007 and 2020.

Results: In South Korea, the crude prevalence of hypercholesterolemia (total cholesterol ≥240 mg/dL or use of a lipid-lowering drug) in 2020 was 24%, and the age-standardized prevalence of hypercholesterolemia more than doubled from 2007 to 2020. The crude treatment rate was 55.2%, and the control rate was 47.7%. The crude prevalence of dyslipidemia (more than one out of three conditions [low-density lipoprotein-cholesterol ≥160 or the use of a lipid-lowering drug, triglycerides ≥200, or high-density lipoprotein-cholesterol (men and women) <40 mg/dL]) was 40.2% between 2016 and 2020. However, it increased to 48.2% when the definition of hypo-high-density lipoprotein-cholesterolemia in women changed from <40 to <50 mg/dL.

Conclusion: Although the prevalence of hypercholesterolemia and dyslipidemia has steadily increased in South Korea, the treatment rate remains low. Therefore, continuous efforts are needed to manage dyslipidemia through cooperation between the national healthcare system, patients, and healthcare providers.
Files in This Item:
T202306210.pdf Download
DOI
10.12997/jla.2023.12.3.237
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers
Yonsei Authors
Kang, Shin Ae(강신애) ORCID logo https://orcid.org/0000-0002-9719-4774
Kim, Hyeon Chang(김현창) ORCID logo https://orcid.org/0000-0001-7867-1240
Shim, Jee Seon(심지선) ORCID logo https://orcid.org/0000-0002-8671-3153
Lee, Hokyou(이호규) ORCID logo https://orcid.org/0000-0002-5034-8422
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/196748
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links